Patent directory · USPTO A61K / A61P
Patents matching “NURIX THERAPEUTICS, INC.”
14 pharma patents match "NURIX THERAPEUTICS, INC." in our USPTO index (A61K/A61P) — applicant, grant date, expiration, and drug links.
Quick answer
This filtered view shows 14 pharmaceutical patents matching "NURIX THERAPEUTICS, INC." in our USPTO PatentsView index (CPC A61K/A61P). Search matches patent number, title, applicant, and CPC classification codes.
Patent results
-
US 12377106
Piperidinylpyrazine-carboxamide compounds for treating and preventing cancer and for degrading BTK
granted -
US 12234230
Substituted benzyl-triazole compounds for Cbl-b inhibition, and further uses thereof
granted -
US 12121540
CBL inhibitors and compositions for use in adoptive cell therapy
granted -
US 12091426
Bifunctional degraders of hematopoietic progenitor kinase and therapeutic uses thereof
granted -
US 12049471
Cyano cyclobutyl compounds for Cbl-b inhibition and uses thereof
granted -
US 12016860
Combination therapies with Cbl-b inhibitor compounds
granted -
US 11951133
3-substituted piperidine compounds for Cbl-b inhibition, and use thereof
granted -
US 11866442
Bifunctional compounds for degrading BTK via ubiquitin proteosome pathway
granted -
US 11820781
Bifunctional compounds for degrading BTK via ubiquitin proteosome pathway
granted -
US 11739101
Bifunctional degraders of hematopoietic progenitor kinase and therapeutic uses thereof
granted -
US 11530229
Cyano cyclobutyl compounds for CBL-B inhibition and uses thereof
granted -
US 11479556
Bifunctional compounds for degrading BTK via ubiquitin proteosome pathway
granted -
US 11464802
3-substituted piperidine compounds for Cbl-b inhibition, and use thereof
granted -
US 11401267
Substituted benzyl-triazole compounds for Cbl-b inhibition, and further uses thereof
granted